Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Ubiquitination/ Proteasome

Items 51-60 of 85

Page
per page
  1. Epoxomicin
    A2606 Epoxomicin
     25 Citation
    Summary: proteasome inhibitor
      ≥27.73 mg/mL
  2. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: Deubiquitylating enzymes (DBUs) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
  3. Celastrol
    A2604 Celastrol
    Target: Proteasome
    Summary: Antioxidant, anti-inflammatory and immunosuppressive agent
      ≥22.55 mg/mL
  4. Paclitaxel (Taxol)
    A4393 Paclitaxel (Taxol)
     27 Citation
    Target: Microtubules/Tubulins
    Summary: microtubule depolymerization inhibitor
      ≥85.6 mg/mL
  5. P 22077
    A8198 P 22077
    Summary: USP7/(DUB)USP47 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.6 mg/mL
  6. Aclacinomycin A
    A2601 Aclacinomycin A
    Target: Topoisomerases
    Summary: Topoisomerase I and II inhibitor
      Soluble in DMSO
  7. Rocilinostat (ACY-1215)
    A4083 Rocilinostat (ACY-1215)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Selective HDAC6 inhibitor
      ≥21.675 mg/mL
  8. Vialinin A
    A4429 Vialinin A
    Target: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2
    Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor
      Soluble in DMSO
  9. Doxorubicin
    A3966 Doxorubicin
     3 Citation
    Summary: DNA topoisomerase II inhibitor
      ≥27.2 mg/mL
  10. ML241 hydrochloride
    B6122 ML241 hydrochloride
    Summary: p97 ATPase inhibitor
      ≥40.9 mg/mL

Items 51-60 of 85

Page
per page